China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Remimazolampropofol combined sedation regimen based on ERAS principles for children undergoing MRI'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136164
Registration Time: 2026/11/06
Type: Interventional study
Primary Sponsor: Shanghai Children's Medical Center Guizhou Hospital, Shanghai Jiao Tong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348059
Published by HT Digital Content Services with permission from Health Daily Digest....